South African executive Gus Attridge has seen a noticeable dip in his wealth following renewed selling pressure on Aspen Pharmacare shares on the Johannesburg Stock Exchange. The slide erased 10.7 million from his holdings, underscoring the pressure facing the continents largest drug manufacturer as global markets remain unsettled.
Attridge, one of Africas pharma executives, owns 4.3 percent of Aspenequal to 19,188,850 shares. At the time of drafting this report, his stake is worth R1.8 billion 104.17 million, down from R1.98 billion 114.86 million on Oct. 28. The R184.4 million 10.7 million decline reflects a broader cooling toward healthcare stocks in emerging markets.
A short rally followed by renewed downward pressure